LADENBURG THALMANN FINANCIAL SERVICES INC. - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 123 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$13,000
+8.3%
3,876
+29.8%
0.00%
Q2 2018$12,0000.0%2,9850.0%0.00%
Q1 2018$12,000
-42.9%
2,985
-33.7%
0.00%
Q4 2017$21,000
-34.4%
4,505
+2.3%
0.00%
Q3 2017$32,000
-17.9%
4,405
-18.5%
0.00%
Q2 2017$39,000
+8.3%
5,405
-8.0%
0.00%
Q1 2017$36,000
+2.9%
5,8750.0%0.00%
Q4 2016$35,000
+12.9%
5,875
+1.7%
0.00%
Q3 2016$31,000
-13.9%
5,775
+3.6%
0.00%
-100.0%
Q2 2016$36,000
+44.0%
5,5750.0%0.00%
Q1 2016$25,000
-10.7%
5,575
+2.0%
0.00%
-100.0%
Q4 2015$28,000
+12.0%
5,466
-19.8%
0.00%0.0%
Q3 2015$25,000
-61.5%
6,815
+4.1%
0.00%0.0%
Q2 2015$65,000
-18.8%
6,545
+4.9%
0.00%
-50.0%
Q1 2015$80,000
-3.6%
6,241
+7.5%
0.00%0.0%
Q4 2014$83,000
+29.7%
5,805
+24.8%
0.00%0.0%
Q3 2014$64,000
-26.4%
4,651
-17.8%
0.00%0.0%
Q2 2014$87,000
-34.6%
5,658
-27.6%
0.00%
-50.0%
Q1 2014$133,000
+24.3%
7,813
-6.2%
0.00%
+33.3%
Q4 2013$107,000
+44.6%
8,332
+17.2%
0.00%0.0%
Q3 2013$74,000
+37.0%
7,111
-1.4%
0.00%
+50.0%
Q2 2013$54,0007,2110.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders